Regeneron Pharmaceuticals, Inc.
High affinity human antibodies to human angiopoietin-2

Last updated:

Abstract:

The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.

Status:
Grant
Type:

Utility

Filling date:

28 Feb 2018

Issue date:

29 Dec 2020